AbbVie Signs Licensing Deal With Sirona Biochem For Effective New Hydroquinone Alternative
AbbVie acquires the rights to market and commercialize Sirona’s breakthrough TFC-1067 compound AbbVie agrees to upfront, milestone, and royalty payments for patented molecules Sirona’s TFC-1067...